B
Bull
Bull · 25%FORA
$2.71
Scenario price
$2.170
+0.010 (+0.46%)At close
Loading chart…
- High
- 2.180
- Open
- 2.160
- VWAP
- 2.17
- Vol
- 87.93K
- Mkt Cap
- 80.96M
- Low
- 2.160
- Amount
- 190.80K
- EV/EBITDA, TTM
- 0.00
Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights.
Valuation Metrics
The current forward P/E ratio for Forian Inc. (FORA) is 23.87, compared to its 5-year average forward P/E of -11.25.
Alphio AI Price Scenarios for FORA
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding FORA
Events Timeline
News
9.508-14Yahoo FinanceVerticalScope Q2 Earnings Report Analysis
9.505-13Yahoo FinanceVerticalScope Q1 Earnings: Revenue Decline Amid User Growth
7.004-24PRnewswireInvestor Rights Law Firm Investigates Multiple Companies
8.504-23PRnewswireInvestigation into Forian Inc. Merger Agreement
8.504-21PRnewswireInvestor Rights Law Firm Investigates Multiple Companies
FORA FAQ — answered by Alphio AI
Forian Inc. is a healthtech company. It is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. It provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers within the healthcare and life sciences and financial services industries. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its solutions include CHRONOS, Chartis, real-world evidence (RWE) and Kyber Data Science. CHRONOS combines open and closed claims, electronic health records, and social determinants of health data into a single, integrated model. It also provides researchers access to healthcare payers, providers, and clinical data with non-traditional healthcare sources, such as social determinants of health (SDoH) data, to uncover novel insights. It operates in the Healthcare sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.